Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Recruiting · NCT06686472 · Registry updated 2024-11-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis | Conjunctival Diseases, Conjunctivitis, Allergic, Hypersensitivity, Immediate, conjunctivitis, eye disorder, immune system disorder | Recruiting | Phase 2 | 2024-11-13 | NCT06686472 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Telios Pharma, Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||